nodes	percent_of_prediction	percent_of_DWPC	metapath
Dasatinib—CYP1B1—glaucoma	0.368	1	CbGaD
Dasatinib—CYP1A1—Clonidine—glaucoma	0.019	0.174	CbGbCtD
Dasatinib—CYP1A2—Betaxolol—glaucoma	0.0155	0.142	CbGbCtD
Dasatinib—CYP3A5—Clonidine—glaucoma	0.0114	0.104	CbGbCtD
Dasatinib—CYP3A4—Pilocarpine—glaucoma	0.00913	0.0834	CbGbCtD
Dasatinib—ABCB1—Timolol—glaucoma	0.00875	0.0799	CbGbCtD
Dasatinib—CYP1A2—Clonidine—glaucoma	0.00851	0.0777	CbGbCtD
Dasatinib—ABCB1—Clonidine—glaucoma	0.00744	0.068	CbGbCtD
Dasatinib—CYP3A4—Brinzolamide—glaucoma	0.00716	0.0654	CbGbCtD
Dasatinib—CYP3A4—Dorzolamide—glaucoma	0.00692	0.0632	CbGbCtD
Dasatinib—CYP3A4—Methazolamide—glaucoma	0.00616	0.0563	CbGbCtD
Dasatinib—CYP3A4—Acetazolamide—glaucoma	0.00493	0.045	CbGbCtD
Dasatinib—CYP3A4—Clonidine—glaucoma	0.00446	0.0407	CbGbCtD
Dasatinib—EPHB1—eye—glaucoma	0.00243	0.0402	CbGeAlD
Dasatinib—EPHB1—retina—glaucoma	0.00241	0.0398	CbGeAlD
Dasatinib—RIPK2—endothelium—glaucoma	0.00232	0.0383	CbGeAlD
Dasatinib—BTK—Treprostinil—Latanoprost—glaucoma	0.0021	0.5	CbGdCrCtD
Dasatinib—SIK2—connective tissue—glaucoma	0.00207	0.0342	CbGeAlD
Dasatinib—EPHB2—retina—glaucoma	0.00198	0.0327	CbGeAlD
Dasatinib—EPHB4—endothelium—glaucoma	0.00196	0.0324	CbGeAlD
Dasatinib—EPHA8—eye—glaucoma	0.00191	0.0316	CbGeAlD
Dasatinib—SRMS—connective tissue—glaucoma	0.00188	0.0311	CbGeAlD
Dasatinib—STAT5B—connective tissue—glaucoma	0.00174	0.0288	CbGeAlD
Dasatinib—EPHA3—eye—glaucoma	0.00167	0.0276	CbGeAlD
Dasatinib—SRC—endothelium—glaucoma	0.00166	0.0275	CbGeAlD
Dasatinib—EPHA3—retina—glaucoma	0.00166	0.0274	CbGeAlD
Dasatinib—ZAK—eye—glaucoma	0.00151	0.025	CbGeAlD
Dasatinib—EPHA5—eye—glaucoma	0.00148	0.0245	CbGeAlD
Dasatinib—EPHA5—retina—glaucoma	0.00147	0.0242	CbGeAlD
Dasatinib—LYN—connective tissue—glaucoma	0.00142	0.0234	CbGeAlD
Dasatinib—BTK—connective tissue—glaucoma	0.00139	0.023	CbGeAlD
Dasatinib—KIT—endothelium—glaucoma	0.00136	0.0224	CbGeAlD
Dasatinib—TESK1—eye—glaucoma	0.00134	0.0221	CbGeAlD
Dasatinib—TESK1—connective tissue—glaucoma	0.00129	0.0213	CbGeAlD
Dasatinib—CSK—eye—glaucoma	0.00122	0.0202	CbGeAlD
Dasatinib—CSK—connective tissue—glaucoma	0.00118	0.0195	CbGeAlD
Dasatinib—RIPK2—eye—glaucoma	0.00114	0.0188	CbGeAlD
Dasatinib—RIPK2—retina—glaucoma	0.00113	0.0186	CbGeAlD
Dasatinib—RIPK2—connective tissue—glaucoma	0.0011	0.0181	CbGeAlD
Dasatinib—SIK1—connective tissue—glaucoma	0.00107	0.0177	CbGeAlD
Dasatinib—ERBB3—connective tissue—glaucoma	0.00105	0.0173	CbGeAlD
Dasatinib—MAP3K2—connective tissue—glaucoma	0.00104	0.0172	CbGeAlD
Dasatinib—MAPK14—connective tissue—glaucoma	0.000976	0.0161	CbGeAlD
Dasatinib—FMO3—eye—glaucoma	0.000975	0.0161	CbGeAlD
Dasatinib—EPHB4—connective tissue—glaucoma	0.000925	0.0153	CbGeAlD
Dasatinib—JAK2—connective tissue—glaucoma	0.000919	0.0152	CbGeAlD
Dasatinib—FYN—connective tissue—glaucoma	0.000906	0.015	CbGeAlD
Dasatinib—YES1—eye—glaucoma	0.000849	0.014	CbGeAlD
Dasatinib—YES1—retina—glaucoma	0.000841	0.0139	CbGeAlD
Dasatinib—YES1—connective tissue—glaucoma	0.000818	0.0135	CbGeAlD
Dasatinib—SRC—eye—glaucoma	0.000817	0.0135	CbGeAlD
Dasatinib—ERBB3—Alprenolol—Metipranolol—glaucoma	0.000811	0.193	CbGdCrCtD
Dasatinib—SRC—retina—glaucoma	0.000809	0.0134	CbGeAlD
Dasatinib—PDGFRA—connective tissue—glaucoma	0.000802	0.0133	CbGeAlD
Dasatinib—SRC—connective tissue—glaucoma	0.000787	0.013	CbGeAlD
Dasatinib—CSF1R—eye—glaucoma	0.000733	0.0121	CbGeAlD
Dasatinib—CSK—Treprostinil—Latanoprost—glaucoma	0.000716	0.171	CbGdCrCtD
Dasatinib—CSF1R—connective tissue—glaucoma	0.000706	0.0117	CbGeAlD
Dasatinib—PDGFRB—eye—glaucoma	0.00065	0.0107	CbGeAlD
Dasatinib—KIT—connective tissue—glaucoma	0.000641	0.0106	CbGeAlD
Dasatinib—PDGFRB—connective tissue—glaucoma	0.000626	0.0104	CbGeAlD
Dasatinib—ABL1—eye—glaucoma	0.00058	0.00958	CbGeAlD
Dasatinib—ABL1—retina—glaucoma	0.000574	0.00949	CbGeAlD
Dasatinib—ERBB3—Alprenolol—Betaxolol—glaucoma	0.000567	0.135	CbGdCrCtD
Dasatinib—ABL1—connective tissue—glaucoma	0.000558	0.00923	CbGeAlD
Dasatinib—CYP1B1—eye—glaucoma	0.000491	0.00811	CbGeAlD
Dasatinib—CYP1B1—connective tissue—glaucoma	0.000473	0.00782	CbGeAlD
Dasatinib—ABCB1—retina—glaucoma	0.000179	0.00295	CbGeAlD
Dasatinib—Immune system disorder—Betaxolol—glaucoma	0.000127	0.000511	CcSEcCtD
Dasatinib—Diarrhoea—Apraclonidine—glaucoma	0.000127	0.00051	CcSEcCtD
Dasatinib—Malaise—Clonidine—glaucoma	0.000127	0.00051	CcSEcCtD
Dasatinib—Mediastinal disorder—Betaxolol—glaucoma	0.000127	0.00051	CcSEcCtD
Dasatinib—Dyspepsia—Pilocarpine—glaucoma	0.000127	0.000509	CcSEcCtD
Dasatinib—Chills—Betaxolol—glaucoma	0.000126	0.000507	CcSEcCtD
Dasatinib—Syncope—Clonidine—glaucoma	0.000126	0.000507	CcSEcCtD
Dasatinib—Arrhythmia—Betaxolol—glaucoma	0.000126	0.000505	CcSEcCtD
Dasatinib—Feeling abnormal—Dorzolamide—glaucoma	0.000125	0.000504	CcSEcCtD
Dasatinib—Decreased appetite—Pilocarpine—glaucoma	0.000125	0.000502	CcSEcCtD
Dasatinib—Feeling abnormal—Travoprost—glaucoma	0.000125	0.000502	CcSEcCtD
Dasatinib—Conjunctivitis—Timolol—glaucoma	0.000124	0.0005	CcSEcCtD
Dasatinib—Gastrointestinal pain—Dorzolamide—glaucoma	0.000124	0.0005	CcSEcCtD
Dasatinib—Alopecia—Betaxolol—glaucoma	0.000124	0.0005	CcSEcCtD
Dasatinib—Palpitations—Clonidine—glaucoma	0.000124	0.0005	CcSEcCtD
Dasatinib—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000124	0.000499	CcSEcCtD
Dasatinib—Gastrointestinal pain—Travoprost—glaucoma	0.000124	0.000498	CcSEcCtD
Dasatinib—Loss of consciousness—Clonidine—glaucoma	0.000124	0.000497	CcSEcCtD
Dasatinib—Feeling abnormal—Brinzolamide—glaucoma	0.000123	0.000495	CcSEcCtD
Dasatinib—Mental disorder—Betaxolol—glaucoma	0.000123	0.000495	CcSEcCtD
Dasatinib—Constipation—Pilocarpine—glaucoma	0.000123	0.000494	CcSEcCtD
Dasatinib—Pain—Pilocarpine—glaucoma	0.000123	0.000494	CcSEcCtD
Dasatinib—Cough—Clonidine—glaucoma	0.000123	0.000493	CcSEcCtD
Dasatinib—Dizziness—Apraclonidine—glaucoma	0.000123	0.000493	CcSEcCtD
Dasatinib—Erythema—Betaxolol—glaucoma	0.000122	0.000492	CcSEcCtD
Dasatinib—Malnutrition—Betaxolol—glaucoma	0.000122	0.000492	CcSEcCtD
Dasatinib—Urticaria—Dorzolamide—glaucoma	0.000121	0.000486	CcSEcCtD
Dasatinib—Epistaxis—Timolol—glaucoma	0.000121	0.000485	CcSEcCtD
Dasatinib—Abdominal pain—Dorzolamide—glaucoma	0.00012	0.000483	CcSEcCtD
Dasatinib—Body temperature increased—Dorzolamide—glaucoma	0.00012	0.000483	CcSEcCtD
Dasatinib—Dysgeusia—Betaxolol—glaucoma	0.00012	0.000482	CcSEcCtD
Dasatinib—Arthralgia—Clonidine—glaucoma	0.00012	0.000481	CcSEcCtD
Dasatinib—Chest pain—Clonidine—glaucoma	0.00012	0.000481	CcSEcCtD
Dasatinib—Abdominal pain—Travoprost—glaucoma	0.00012	0.000481	CcSEcCtD
Dasatinib—Anxiety—Clonidine—glaucoma	0.000119	0.00048	CcSEcCtD
Dasatinib—Asthenia—Acetazolamide—glaucoma	0.000119	0.000479	CcSEcCtD
Dasatinib—Dizziness—Bimatoprost—glaucoma	0.000119	0.000478	CcSEcCtD
Dasatinib—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000119	0.000478	CcSEcCtD
Dasatinib—Urticaria—Brinzolamide—glaucoma	0.000119	0.000478	CcSEcCtD
Dasatinib—Feeling abnormal—Pilocarpine—glaucoma	0.000118	0.000476	CcSEcCtD
Dasatinib—Discomfort—Clonidine—glaucoma	0.000118	0.000476	CcSEcCtD
Dasatinib—Vomiting—Apraclonidine—glaucoma	0.000118	0.000474	CcSEcCtD
Dasatinib—Muscle spasms—Betaxolol—glaucoma	0.000118	0.000473	CcSEcCtD
Dasatinib—Gastrointestinal pain—Pilocarpine—glaucoma	0.000118	0.000472	CcSEcCtD
Dasatinib—Hypersensitivity—Brimonidine—glaucoma	0.000117	0.000472	CcSEcCtD
Dasatinib—Dermatitis—Apraclonidine—glaucoma	0.000117	0.00047	CcSEcCtD
Dasatinib—Headache—Apraclonidine—glaucoma	0.000116	0.000467	CcSEcCtD
Dasatinib—Confusional state—Clonidine—glaucoma	0.000116	0.000465	CcSEcCtD
Dasatinib—Vision blurred—Betaxolol—glaucoma	0.000115	0.000464	CcSEcCtD
Dasatinib—Oedema—Clonidine—glaucoma	0.000115	0.000461	CcSEcCtD
Dasatinib—Tremor—Betaxolol—glaucoma	0.000115	0.000461	CcSEcCtD
Dasatinib—Asthenia—Brimonidine—glaucoma	0.000114	0.000459	CcSEcCtD
Dasatinib—Infection—Clonidine—glaucoma	0.000114	0.000458	CcSEcCtD
Dasatinib—Abdominal pain—Pilocarpine—glaucoma	0.000114	0.000457	CcSEcCtD
Dasatinib—Body temperature increased—Pilocarpine—glaucoma	0.000114	0.000457	CcSEcCtD
Dasatinib—Ill-defined disorder—Betaxolol—glaucoma	0.000114	0.000457	CcSEcCtD
Dasatinib—Diarrhoea—Acetazolamide—glaucoma	0.000114	0.000456	CcSEcCtD
Dasatinib—Rash—Bimatoprost—glaucoma	0.000113	0.000456	CcSEcCtD
Dasatinib—Dermatitis—Bimatoprost—glaucoma	0.000113	0.000456	CcSEcCtD
Dasatinib—Oedema peripheral—Timolol—glaucoma	0.000113	0.000455	CcSEcCtD
Dasatinib—Anaemia—Betaxolol—glaucoma	0.000113	0.000455	CcSEcCtD
Dasatinib—Shock—Clonidine—glaucoma	0.000113	0.000454	CcSEcCtD
Dasatinib—Connective tissue disorder—Timolol—glaucoma	0.000113	0.000454	CcSEcCtD
Dasatinib—Pruritus—Brimonidine—glaucoma	0.000113	0.000453	CcSEcCtD
Dasatinib—Headache—Bimatoprost—glaucoma	0.000113	0.000453	CcSEcCtD
Dasatinib—Nervous system disorder—Clonidine—glaucoma	0.000113	0.000453	CcSEcCtD
Dasatinib—Thrombocytopenia—Clonidine—glaucoma	0.000112	0.000452	CcSEcCtD
Dasatinib—Hypersensitivity—Dorzolamide—glaucoma	0.000112	0.000451	CcSEcCtD
Dasatinib—Tachycardia—Clonidine—glaucoma	0.000112	0.00045	CcSEcCtD
Dasatinib—Hypersensitivity—Travoprost—glaucoma	0.000112	0.000449	CcSEcCtD
Dasatinib—Skin disorder—Clonidine—glaucoma	0.000112	0.000448	CcSEcCtD
Dasatinib—Hyperhidrosis—Clonidine—glaucoma	0.000111	0.000446	CcSEcCtD
Dasatinib—Visual impairment—Timolol—glaucoma	0.000111	0.000445	CcSEcCtD
Dasatinib—Malaise—Betaxolol—glaucoma	0.00011	0.000444	CcSEcCtD
Dasatinib—Nausea—Apraclonidine—glaucoma	0.00011	0.000443	CcSEcCtD
Dasatinib—Hypersensitivity—Brinzolamide—glaucoma	0.00011	0.000443	CcSEcCtD
Dasatinib—Vertigo—Betaxolol—glaucoma	0.00011	0.000442	CcSEcCtD
Dasatinib—Syncope—Betaxolol—glaucoma	0.00011	0.000441	CcSEcCtD
Dasatinib—Dizziness—Acetazolamide—glaucoma	0.00011	0.000441	CcSEcCtD
Dasatinib—Anorexia—Clonidine—glaucoma	0.000109	0.00044	CcSEcCtD
Dasatinib—Asthenia—Dorzolamide—glaucoma	0.000109	0.000439	CcSEcCtD
Dasatinib—Asthenia—Travoprost—glaucoma	0.000109	0.000437	CcSEcCtD
Dasatinib—Palpitations—Betaxolol—glaucoma	0.000108	0.000435	CcSEcCtD
Dasatinib—Pruritus—Dorzolamide—glaucoma	0.000108	0.000433	CcSEcCtD
Dasatinib—Loss of consciousness—Betaxolol—glaucoma	0.000108	0.000433	CcSEcCtD
Dasatinib—Eye disorder—Timolol—glaucoma	0.000107	0.000432	CcSEcCtD
Dasatinib—Asthenia—Brinzolamide—glaucoma	0.000107	0.000431	CcSEcCtD
Dasatinib—Hypotension—Clonidine—glaucoma	0.000107	0.000431	CcSEcCtD
Dasatinib—Pruritus—Travoprost—glaucoma	0.000107	0.000431	CcSEcCtD
Dasatinib—Tinnitus—Timolol—glaucoma	0.000107	0.000431	CcSEcCtD
Dasatinib—Cough—Betaxolol—glaucoma	0.000107	0.00043	CcSEcCtD
Dasatinib—Nausea—Bimatoprost—glaucoma	0.000107	0.00043	CcSEcCtD
Dasatinib—Cardiac disorder—Timolol—glaucoma	0.000107	0.000429	CcSEcCtD
Dasatinib—Hypersensitivity—Pilocarpine—glaucoma	0.000106	0.000426	CcSEcCtD
Dasatinib—Pruritus—Brinzolamide—glaucoma	0.000106	0.000425	CcSEcCtD
Dasatinib—Vomiting—Acetazolamide—glaucoma	0.000106	0.000424	CcSEcCtD
Dasatinib—Dizziness—Brimonidine—glaucoma	0.000105	0.000423	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Clonidine—glaucoma	0.000105	0.00042	CcSEcCtD
Dasatinib—Angiopathy—Timolol—glaucoma	0.000104	0.000419	CcSEcCtD
Dasatinib—Chest pain—Betaxolol—glaucoma	0.000104	0.000419	CcSEcCtD
Dasatinib—Arthralgia—Betaxolol—glaucoma	0.000104	0.000419	CcSEcCtD
Dasatinib—Myalgia—Betaxolol—glaucoma	0.000104	0.000419	CcSEcCtD
Dasatinib—Diarrhoea—Dorzolamide—glaucoma	0.000104	0.000418	CcSEcCtD
Dasatinib—Headache—Acetazolamide—glaucoma	0.000104	0.000418	CcSEcCtD
Dasatinib—Anxiety—Betaxolol—glaucoma	0.000104	0.000418	CcSEcCtD
Dasatinib—Insomnia—Clonidine—glaucoma	0.000104	0.000417	CcSEcCtD
Dasatinib—Immune system disorder—Timolol—glaucoma	0.000104	0.000417	CcSEcCtD
Dasatinib—Diarrhoea—Travoprost—glaucoma	0.000104	0.000417	CcSEcCtD
Dasatinib—Mediastinal disorder—Timolol—glaucoma	0.000104	0.000416	CcSEcCtD
Dasatinib—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000104	0.000416	CcSEcCtD
Dasatinib—Asthenia—Pilocarpine—glaucoma	0.000103	0.000415	CcSEcCtD
Dasatinib—Discomfort—Betaxolol—glaucoma	0.000103	0.000414	CcSEcCtD
Dasatinib—Arrhythmia—Timolol—glaucoma	0.000103	0.000413	CcSEcCtD
Dasatinib—Dyspnoea—Clonidine—glaucoma	0.000102	0.000411	CcSEcCtD
Dasatinib—Diarrhoea—Brinzolamide—glaucoma	0.000102	0.000411	CcSEcCtD
Dasatinib—Somnolence—Clonidine—glaucoma	0.000102	0.00041	CcSEcCtD
Dasatinib—Pruritus—Pilocarpine—glaucoma	0.000102	0.000409	CcSEcCtD
Dasatinib—Alopecia—Timolol—glaucoma	0.000102	0.000408	CcSEcCtD
Dasatinib—Confusional state—Betaxolol—glaucoma	0.000101	0.000405	CcSEcCtD
Dasatinib—Mental disorder—Timolol—glaucoma	0.000101	0.000405	CcSEcCtD
Dasatinib—Dizziness—Dorzolamide—glaucoma	0.000101	0.000404	CcSEcCtD
Dasatinib—Rash—Brimonidine—glaucoma	0.0001	0.000404	CcSEcCtD
Dasatinib—Dermatitis—Brimonidine—glaucoma	0.0001	0.000403	CcSEcCtD
Dasatinib—Dizziness—Travoprost—glaucoma	0.0001	0.000403	CcSEcCtD
Dasatinib—Malnutrition—Timolol—glaucoma	0.0001	0.000402	CcSEcCtD
Dasatinib—Erythema—Timolol—glaucoma	0.0001	0.000402	CcSEcCtD
Dasatinib—Oedema—Betaxolol—glaucoma	0.0001	0.000402	CcSEcCtD
Dasatinib—Headache—Brimonidine—glaucoma	9.98e-05	0.000401	CcSEcCtD
Dasatinib—Decreased appetite—Clonidine—glaucoma	9.98e-05	0.000401	CcSEcCtD
Dasatinib—Infection—Betaxolol—glaucoma	9.93e-05	0.000399	CcSEcCtD
Dasatinib—Gastrointestinal disorder—Clonidine—glaucoma	9.91e-05	0.000398	CcSEcCtD
Dasatinib—Fatigue—Clonidine—glaucoma	9.9e-05	0.000398	CcSEcCtD
Dasatinib—Dizziness—Brinzolamide—glaucoma	9.89e-05	0.000398	CcSEcCtD
Dasatinib—Nausea—Acetazolamide—glaucoma	9.86e-05	0.000396	CcSEcCtD
Dasatinib—Diarrhoea—Pilocarpine—glaucoma	9.84e-05	0.000395	CcSEcCtD
Dasatinib—Shock—Betaxolol—glaucoma	9.84e-05	0.000395	CcSEcCtD
Dasatinib—Constipation—Clonidine—glaucoma	9.82e-05	0.000395	CcSEcCtD
Dasatinib—Pain—Clonidine—glaucoma	9.82e-05	0.000395	CcSEcCtD
Dasatinib—Nervous system disorder—Betaxolol—glaucoma	9.8e-05	0.000394	CcSEcCtD
Dasatinib—Dysgeusia—Timolol—glaucoma	9.8e-05	0.000394	CcSEcCtD
Dasatinib—Thrombocytopenia—Betaxolol—glaucoma	9.79e-05	0.000393	CcSEcCtD
Dasatinib—Tachycardia—Betaxolol—glaucoma	9.76e-05	0.000392	CcSEcCtD
Dasatinib—Skin disorder—Betaxolol—glaucoma	9.71e-05	0.00039	CcSEcCtD
Dasatinib—Vomiting—Dorzolamide—glaucoma	9.68e-05	0.000389	CcSEcCtD
Dasatinib—Hyperhidrosis—Betaxolol—glaucoma	9.66e-05	0.000388	CcSEcCtD
Dasatinib—Rash—Dorzolamide—glaucoma	9.59e-05	0.000386	CcSEcCtD
Dasatinib—Dermatitis—Dorzolamide—glaucoma	9.59e-05	0.000385	CcSEcCtD
Dasatinib—Rash—Travoprost—glaucoma	9.55e-05	0.000384	CcSEcCtD
Dasatinib—Dermatitis—Travoprost—glaucoma	9.54e-05	0.000384	CcSEcCtD
Dasatinib—Headache—Dorzolamide—glaucoma	9.53e-05	0.000383	CcSEcCtD
Dasatinib—Anorexia—Betaxolol—glaucoma	9.53e-05	0.000383	CcSEcCtD
Dasatinib—Vomiting—Brinzolamide—glaucoma	9.51e-05	0.000382	CcSEcCtD
Dasatinib—Dizziness—Pilocarpine—glaucoma	9.51e-05	0.000382	CcSEcCtD
Dasatinib—Headache—Travoprost—glaucoma	9.49e-05	0.000381	CcSEcCtD
Dasatinib—Nausea—Brimonidine—glaucoma	9.46e-05	0.00038	CcSEcCtD
Dasatinib—Feeling abnormal—Clonidine—glaucoma	9.46e-05	0.00038	CcSEcCtD
Dasatinib—Rash—Brinzolamide—glaucoma	9.43e-05	0.000379	CcSEcCtD
Dasatinib—Vision blurred—Timolol—glaucoma	9.43e-05	0.000379	CcSEcCtD
Dasatinib—Dermatitis—Brinzolamide—glaucoma	9.42e-05	0.000379	CcSEcCtD
Dasatinib—Gastrointestinal pain—Clonidine—glaucoma	9.39e-05	0.000377	CcSEcCtD
Dasatinib—Headache—Brinzolamide—glaucoma	9.37e-05	0.000377	CcSEcCtD
Dasatinib—Hypotension—Betaxolol—glaucoma	9.34e-05	0.000375	CcSEcCtD
Dasatinib—Vomiting—Pilocarpine—glaucoma	9.14e-05	0.000367	CcSEcCtD
Dasatinib—Urticaria—Clonidine—glaucoma	9.12e-05	0.000367	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Betaxolol—glaucoma	9.11e-05	0.000366	CcSEcCtD
Dasatinib—Abdominal pain—Clonidine—glaucoma	9.08e-05	0.000365	CcSEcCtD
Dasatinib—Body temperature increased—Clonidine—glaucoma	9.08e-05	0.000365	CcSEcCtD
Dasatinib—Rash—Pilocarpine—glaucoma	9.07e-05	0.000364	CcSEcCtD
Dasatinib—Dermatitis—Pilocarpine—glaucoma	9.06e-05	0.000364	CcSEcCtD
Dasatinib—Insomnia—Betaxolol—glaucoma	9.04e-05	0.000363	CcSEcCtD
Dasatinib—Nausea—Dorzolamide—glaucoma	9.04e-05	0.000363	CcSEcCtD
Dasatinib—Headache—Pilocarpine—glaucoma	9.01e-05	0.000362	CcSEcCtD
Dasatinib—Nausea—Travoprost—glaucoma	9e-05	0.000362	CcSEcCtD
Dasatinib—Vertigo—Timolol—glaucoma	8.99e-05	0.000361	CcSEcCtD
Dasatinib—Syncope—Timolol—glaucoma	8.97e-05	0.000361	CcSEcCtD
Dasatinib—Dyspnoea—Betaxolol—glaucoma	8.91e-05	0.000358	CcSEcCtD
Dasatinib—Nausea—Brinzolamide—glaucoma	8.89e-05	0.000357	CcSEcCtD
Dasatinib—Palpitations—Timolol—glaucoma	8.84e-05	0.000355	CcSEcCtD
Dasatinib—Dyspepsia—Betaxolol—glaucoma	8.8e-05	0.000354	CcSEcCtD
Dasatinib—Loss of consciousness—Timolol—glaucoma	8.8e-05	0.000353	CcSEcCtD
Dasatinib—Cough—Timolol—glaucoma	8.73e-05	0.000351	CcSEcCtD
Dasatinib—Decreased appetite—Betaxolol—glaucoma	8.69e-05	0.000349	CcSEcCtD
Dasatinib—Hypertension—Timolol—glaucoma	8.64e-05	0.000347	CcSEcCtD
Dasatinib—Gastrointestinal disorder—Betaxolol—glaucoma	8.63e-05	0.000347	CcSEcCtD
Dasatinib—Fatigue—Betaxolol—glaucoma	8.62e-05	0.000346	CcSEcCtD
Dasatinib—Constipation—Betaxolol—glaucoma	8.55e-05	0.000344	CcSEcCtD
Dasatinib—Pain—Betaxolol—glaucoma	8.55e-05	0.000344	CcSEcCtD
Dasatinib—Nausea—Pilocarpine—glaucoma	8.54e-05	0.000343	CcSEcCtD
Dasatinib—Myalgia—Timolol—glaucoma	8.52e-05	0.000342	CcSEcCtD
Dasatinib—Chest pain—Timolol—glaucoma	8.52e-05	0.000342	CcSEcCtD
Dasatinib—Arthralgia—Timolol—glaucoma	8.52e-05	0.000342	CcSEcCtD
Dasatinib—Anxiety—Timolol—glaucoma	8.49e-05	0.000341	CcSEcCtD
Dasatinib—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	8.46e-05	0.00034	CcSEcCtD
Dasatinib—Hypersensitivity—Clonidine—glaucoma	8.46e-05	0.00034	CcSEcCtD
Dasatinib—Discomfort—Timolol—glaucoma	8.42e-05	0.000338	CcSEcCtD
Dasatinib—Asthenia—Clonidine—glaucoma	8.24e-05	0.000331	CcSEcCtD
Dasatinib—Feeling abnormal—Betaxolol—glaucoma	8.24e-05	0.000331	CcSEcCtD
Dasatinib—Confusional state—Timolol—glaucoma	8.23e-05	0.000331	CcSEcCtD
Dasatinib—Oedema—Timolol—glaucoma	8.17e-05	0.000328	CcSEcCtD
Dasatinib—Pruritus—Clonidine—glaucoma	8.12e-05	0.000326	CcSEcCtD
Dasatinib—Infection—Timolol—glaucoma	8.11e-05	0.000326	CcSEcCtD
Dasatinib—Shock—Timolol—glaucoma	8.03e-05	0.000323	CcSEcCtD
Dasatinib—Nervous system disorder—Timolol—glaucoma	8.01e-05	0.000322	CcSEcCtD
Dasatinib—Urticaria—Betaxolol—glaucoma	7.94e-05	0.000319	CcSEcCtD
Dasatinib—Skin disorder—Timolol—glaucoma	7.93e-05	0.000319	CcSEcCtD
Dasatinib—Body temperature increased—Betaxolol—glaucoma	7.9e-05	0.000318	CcSEcCtD
Dasatinib—Hyperhidrosis—Timolol—glaucoma	7.9e-05	0.000317	CcSEcCtD
Dasatinib—Diarrhoea—Clonidine—glaucoma	7.86e-05	0.000316	CcSEcCtD
Dasatinib—Anorexia—Timolol—glaucoma	7.78e-05	0.000313	CcSEcCtD
Dasatinib—Hypotension—Timolol—glaucoma	7.63e-05	0.000307	CcSEcCtD
Dasatinib—Dizziness—Clonidine—glaucoma	7.59e-05	0.000305	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Timolol—glaucoma	7.44e-05	0.000299	CcSEcCtD
Dasatinib—Insomnia—Timolol—glaucoma	7.39e-05	0.000297	CcSEcCtD
Dasatinib—Hypersensitivity—Betaxolol—glaucoma	7.37e-05	0.000296	CcSEcCtD
Dasatinib—Vomiting—Clonidine—glaucoma	7.3e-05	0.000293	CcSEcCtD
Dasatinib—Dyspnoea—Timolol—glaucoma	7.28e-05	0.000293	CcSEcCtD
Dasatinib—Somnolence—Timolol—glaucoma	7.26e-05	0.000292	CcSEcCtD
Dasatinib—Rash—Clonidine—glaucoma	7.24e-05	0.000291	CcSEcCtD
Dasatinib—Dermatitis—Clonidine—glaucoma	7.23e-05	0.000291	CcSEcCtD
Dasatinib—Headache—Clonidine—glaucoma	7.19e-05	0.000289	CcSEcCtD
Dasatinib—Dyspepsia—Timolol—glaucoma	7.19e-05	0.000289	CcSEcCtD
Dasatinib—Asthenia—Betaxolol—glaucoma	7.17e-05	0.000288	CcSEcCtD
Dasatinib—Decreased appetite—Timolol—glaucoma	7.1e-05	0.000285	CcSEcCtD
Dasatinib—Pruritus—Betaxolol—glaucoma	7.07e-05	0.000284	CcSEcCtD
Dasatinib—Gastrointestinal disorder—Timolol—glaucoma	7.05e-05	0.000283	CcSEcCtD
Dasatinib—Fatigue—Timolol—glaucoma	7.04e-05	0.000283	CcSEcCtD
Dasatinib—Pain—Timolol—glaucoma	6.98e-05	0.000281	CcSEcCtD
Dasatinib—Diarrhoea—Betaxolol—glaucoma	6.84e-05	0.000275	CcSEcCtD
Dasatinib—Nausea—Clonidine—glaucoma	6.82e-05	0.000274	CcSEcCtD
Dasatinib—Feeling abnormal—Timolol—glaucoma	6.73e-05	0.00027	CcSEcCtD
Dasatinib—Gastrointestinal pain—Timolol—glaucoma	6.68e-05	0.000268	CcSEcCtD
Dasatinib—Dizziness—Betaxolol—glaucoma	6.61e-05	0.000266	CcSEcCtD
Dasatinib—Urticaria—Timolol—glaucoma	6.49e-05	0.000261	CcSEcCtD
Dasatinib—Abdominal pain—Timolol—glaucoma	6.46e-05	0.000259	CcSEcCtD
Dasatinib—Body temperature increased—Timolol—glaucoma	6.46e-05	0.000259	CcSEcCtD
Dasatinib—Vomiting—Betaxolol—glaucoma	6.36e-05	0.000255	CcSEcCtD
Dasatinib—Rash—Betaxolol—glaucoma	6.3e-05	0.000253	CcSEcCtD
Dasatinib—Dermatitis—Betaxolol—glaucoma	6.3e-05	0.000253	CcSEcCtD
Dasatinib—Headache—Betaxolol—glaucoma	6.26e-05	0.000252	CcSEcCtD
Dasatinib—Hypersensitivity—Timolol—glaucoma	6.02e-05	0.000242	CcSEcCtD
Dasatinib—Nausea—Betaxolol—glaucoma	5.94e-05	0.000239	CcSEcCtD
Dasatinib—Asthenia—Timolol—glaucoma	5.86e-05	0.000235	CcSEcCtD
Dasatinib—Pruritus—Timolol—glaucoma	5.78e-05	0.000232	CcSEcCtD
Dasatinib—Diarrhoea—Timolol—glaucoma	5.59e-05	0.000225	CcSEcCtD
Dasatinib—Dizziness—Timolol—glaucoma	5.4e-05	0.000217	CcSEcCtD
Dasatinib—Vomiting—Timolol—glaucoma	5.19e-05	0.000209	CcSEcCtD
Dasatinib—Rash—Timolol—glaucoma	5.15e-05	0.000207	CcSEcCtD
Dasatinib—Dermatitis—Timolol—glaucoma	5.14e-05	0.000207	CcSEcCtD
Dasatinib—Headache—Timolol—glaucoma	5.12e-05	0.000206	CcSEcCtD
Dasatinib—Nausea—Timolol—glaucoma	4.85e-05	0.000195	CcSEcCtD
Dasatinib—JAK2—Disease—BAD—glaucoma	4.58e-06	2.19e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—NTRK2—glaucoma	4.55e-06	2.18e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—EDN1—glaucoma	4.52e-06	2.16e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—GSTT1—glaucoma	4.51e-06	2.16e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—C3—glaucoma	4.47e-06	2.14e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—CDKN2B—glaucoma	4.46e-06	2.14e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—NOS3—glaucoma	4.46e-06	2.13e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—EDN1—glaucoma	4.45e-06	2.13e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—CA1—glaucoma	4.44e-06	2.12e-05	CbGpPWpGaD
Dasatinib—SRC—Immune System—C3—glaucoma	4.43e-06	2.12e-05	CbGpPWpGaD
Dasatinib—LYN—Hemostasis—TP53—glaucoma	4.42e-06	2.12e-05	CbGpPWpGaD
Dasatinib—KIT—Immune System—CDKN1B—glaucoma	4.42e-06	2.11e-05	CbGpPWpGaD
Dasatinib—SRC—Adaptive Immune System—CDKN1B—glaucoma	4.41e-06	2.11e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—NGFR—glaucoma	4.41e-06	2.11e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—CDKN2B—glaucoma	4.41e-06	2.11e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—APOE—glaucoma	4.4e-06	2.11e-05	CbGpPWpGaD
Dasatinib—ABL1—Hemostasis—TP53—glaucoma	4.4e-06	2.11e-05	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—NOS3—glaucoma	4.36e-06	2.09e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—CAV1—glaucoma	4.36e-06	2.09e-05	CbGpPWpGaD
Dasatinib—FYN—Hemostasis—TP53—glaucoma	4.35e-06	2.08e-05	CbGpPWpGaD
Dasatinib—LCK—Immune System—BAD—glaucoma	4.34e-06	2.08e-05	CbGpPWpGaD
Dasatinib—SRC—Developmental Biology—VEGFA—glaucoma	4.33e-06	2.07e-05	CbGpPWpGaD
Dasatinib—KIT—Disease—PTGS2—glaucoma	4.31e-06	2.06e-05	CbGpPWpGaD
Dasatinib—LCK—Disease—APOE—glaucoma	4.3e-06	2.06e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—CTSA—glaucoma	4.3e-06	2.06e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—EDN1—glaucoma	4.28e-06	2.05e-05	CbGpPWpGaD
Dasatinib—LCK—Disease—CAV1—glaucoma	4.26e-06	2.04e-05	CbGpPWpGaD
Dasatinib—SRC—Hemostasis—VEGFA—glaucoma	4.24e-06	2.03e-05	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—GSTM1—glaucoma	4.24e-06	2.03e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—NGF—glaucoma	4.24e-06	2.03e-05	CbGpPWpGaD
Dasatinib—SRC—Immune System—BCL2L1—glaucoma	4.24e-06	2.03e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—EDN1—glaucoma	4.23e-06	2.02e-05	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—NOS3—glaucoma	4.21e-06	2.01e-05	CbGpPWpGaD
Dasatinib—MAPK14—Hemostasis—TP53—glaucoma	4.19e-06	2.01e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—NTRK1—glaucoma	4.19e-06	2e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—CDKN1B—glaucoma	4.18e-06	2e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—APOE—glaucoma	4.17e-06	1.99e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—NGF—glaucoma	4.15e-06	1.99e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—FN1—glaucoma	4.15e-06	1.99e-05	CbGpPWpGaD
Dasatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	4.14e-06	1.98e-05	CbGpPWpGaD
Dasatinib—JAK2—Hemostasis—TP53—glaucoma	4.14e-06	1.98e-05	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—CDKN1B—glaucoma	4.13e-06	1.98e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—CAV1—glaucoma	4.13e-06	1.98e-05	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—MTHFR—glaucoma	4.12e-06	1.97e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—BAD—glaucoma	4.1e-06	1.96e-05	CbGpPWpGaD
Dasatinib—SRC—Disease—MTHFR—glaucoma	4.09e-06	1.96e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—NGF—glaucoma	4.09e-06	1.96e-05	CbGpPWpGaD
Dasatinib—KIT—Disease—CDKN1B—glaucoma	4.08e-06	1.95e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—PTGS2—glaucoma	4.08e-06	1.95e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—CA2—glaucoma	4.06e-06	1.94e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—C3—glaucoma	4.03e-06	1.93e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—NOS3—glaucoma	4.01e-06	1.92e-05	CbGpPWpGaD
Dasatinib—LCK—Disease—BAD—glaucoma	4.01e-06	1.92e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—C3—glaucoma	3.95e-06	1.89e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—NGF—glaucoma	3.94e-06	1.88e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—FN1—glaucoma	3.93e-06	1.88e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—NGFR—glaucoma	3.9e-06	1.87e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—C3—glaucoma	3.89e-06	1.86e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—NGF—glaucoma	3.89e-06	1.86e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—BAD—glaucoma	3.88e-06	1.86e-05	CbGpPWpGaD
Dasatinib—FYN—Disease—NOS3—glaucoma	3.87e-06	1.85e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—CDKN1B—glaucoma	3.86e-06	1.85e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—CDKN2B—glaucoma	3.86e-06	1.85e-05	CbGpPWpGaD
Dasatinib—SRC—Immune System—BAD—glaucoma	3.84e-06	1.84e-05	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—APOE—glaucoma	3.84e-06	1.84e-05	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—MMP9—glaucoma	3.83e-06	1.83e-05	CbGpPWpGaD
Dasatinib—SRC—Disease—APOE—glaucoma	3.81e-06	1.82e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—CYP1B1—glaucoma	3.8e-06	1.82e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—ABCA1—glaucoma	3.8e-06	1.82e-05	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—CAV1—glaucoma	3.8e-06	1.82e-05	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—CDKN1B—glaucoma	3.78e-06	1.81e-05	CbGpPWpGaD
Dasatinib—SRC—Disease—CAV1—glaucoma	3.77e-06	1.81e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—CDKN1B—glaucoma	3.77e-06	1.8e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—APOE—glaucoma	3.75e-06	1.8e-05	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—MTHFR—glaucoma	3.75e-06	1.79e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—C3—glaucoma	3.74e-06	1.79e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—CAV1—glaucoma	3.72e-06	1.78e-05	CbGpPWpGaD
Dasatinib—SRC—Developmental Biology—TNF—glaucoma	3.71e-06	1.77e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—NTRK1—glaucoma	3.71e-06	1.77e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—TXN—glaucoma	3.71e-06	1.77e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—EDN1—glaucoma	3.7e-06	1.77e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—C3—glaucoma	3.69e-06	1.77e-05	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—NOS3—glaucoma	3.69e-06	1.77e-05	CbGpPWpGaD
Dasatinib—LYN—Immune System—CDKN1B—glaucoma	3.69e-06	1.77e-05	CbGpPWpGaD
Dasatinib—JAK2—Disease—NOS3—glaucoma	3.68e-06	1.76e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—APOE—glaucoma	3.67e-06	1.76e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—PTGS2—glaucoma	3.67e-06	1.76e-05	CbGpPWpGaD
Dasatinib—ABL1—Immune System—CDKN1B—glaucoma	3.67e-06	1.76e-05	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—CDKN1B—glaucoma	3.64e-06	1.74e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—CAV1—glaucoma	3.64e-06	1.74e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	3.63e-06	1.74e-05	CbGpPWpGaD
Dasatinib—FYN—Immune System—CDKN1B—glaucoma	3.63e-06	1.74e-05	CbGpPWpGaD
Dasatinib—LCK—Hemostasis—TP53—glaucoma	3.62e-06	1.73e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—APOE—glaucoma	3.62e-06	1.73e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—GSTT1—glaucoma	3.6e-06	1.72e-05	CbGpPWpGaD
Dasatinib—CSK—Signaling Pathways—TP53—glaucoma	3.59e-06	1.72e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—CYP1B1—glaucoma	3.59e-06	1.72e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—ABCA1—glaucoma	3.59e-06	1.72e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—CAV1—glaucoma	3.58e-06	1.72e-05	CbGpPWpGaD
Dasatinib—SRC—Disease—BAD—glaucoma	3.55e-06	1.7e-05	CbGpPWpGaD
Dasatinib—FYN—Disease—PTGS2—glaucoma	3.54e-06	1.69e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—FN1—glaucoma	3.54e-06	1.69e-05	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—MMP9—glaucoma	3.5e-06	1.68e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—BAD—glaucoma	3.5e-06	1.67e-05	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—CDKN1B—glaucoma	3.5e-06	1.67e-05	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—APOE—glaucoma	3.49e-06	1.67e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—APOE—glaucoma	3.48e-06	1.67e-05	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—TP53—glaucoma	3.48e-06	1.66e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—CDKN1B—glaucoma	3.48e-06	1.66e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—FN1—glaucoma	3.46e-06	1.66e-05	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—CAV1—glaucoma	3.46e-06	1.65e-05	CbGpPWpGaD
Dasatinib—JAK2—Immune System—CDKN1B—glaucoma	3.45e-06	1.65e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—CAV1—glaucoma	3.45e-06	1.65e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—APOE—glaucoma	3.44e-06	1.65e-05	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—VEGFA—glaucoma	3.44e-06	1.64e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—BAD—glaucoma	3.42e-06	1.64e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—CDKN2B—glaucoma	3.42e-06	1.64e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—FN1—glaucoma	3.41e-06	1.63e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—CAV1—glaucoma	3.41e-06	1.63e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—NGF—glaucoma	3.4e-06	1.63e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	3.38e-06	1.62e-05	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—MMP9—glaucoma	3.37e-06	1.61e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—BAD—glaucoma	3.37e-06	1.61e-05	CbGpPWpGaD
Dasatinib—JAK2—Disease—PTGS2—glaucoma	3.36e-06	1.61e-05	CbGpPWpGaD
Dasatinib—FYN—Disease—CDKN1B—glaucoma	3.35e-06	1.6e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	3.35e-06	1.6e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—NOS3—glaucoma	3.3e-06	1.58e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—FN1—glaucoma	3.28e-06	1.57e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—EDN1—glaucoma	3.28e-06	1.57e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—BAD—glaucoma	3.25e-06	1.55e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—FN1—glaucoma	3.24e-06	1.55e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—C3—glaucoma	3.23e-06	1.55e-05	CbGpPWpGaD
Dasatinib—LCK—Disease—NOS3—glaucoma	3.22e-06	1.54e-05	CbGpPWpGaD
Dasatinib—SRC—Hemostasis—TP53—glaucoma	3.21e-06	1.54e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—BAD—glaucoma	3.2e-06	1.53e-05	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—CDKN1B—glaucoma	3.2e-06	1.53e-05	CbGpPWpGaD
Dasatinib—JAK2—Disease—CDKN1B—glaucoma	3.19e-06	1.53e-05	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—VEGFA—glaucoma	3.14e-06	1.5e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—NOS3—glaucoma	3.12e-06	1.49e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—GSTM1—glaucoma	3.04e-06	1.45e-05	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—VEGFA—glaucoma	3.03e-06	1.45e-05	CbGpPWpGaD
Dasatinib—LCK—Immune System—CDKN1B—glaucoma	3.02e-06	1.45e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—NGF—glaucoma	3.01e-06	1.44e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—APOE—glaucoma	3.01e-06	1.44e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—CAV1—glaucoma	2.98e-06	1.43e-05	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—MMP9—glaucoma	2.96e-06	1.42e-05	CbGpPWpGaD
Dasatinib—LCK—Disease—PTGS2—glaucoma	2.95e-06	1.41e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—GSTT1—glaucoma	2.87e-06	1.38e-05	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—NOS3—glaucoma	2.87e-06	1.38e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—GSTM1—glaucoma	2.87e-06	1.37e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—CYP1B1—glaucoma	2.87e-06	1.37e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—ABCA1—glaucoma	2.87e-06	1.37e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—C3—glaucoma	2.86e-06	1.37e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—TXN—glaucoma	2.86e-06	1.37e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—CDKN1B—glaucoma	2.86e-06	1.37e-05	CbGpPWpGaD
Dasatinib—SRC—Disease—NOS3—glaucoma	2.85e-06	1.37e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—FN1—glaucoma	2.84e-06	1.36e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—NOS3—glaucoma	2.81e-06	1.35e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—BAD—glaucoma	2.81e-06	1.34e-05	CbGpPWpGaD
Dasatinib—LCK—Disease—CDKN1B—glaucoma	2.79e-06	1.34e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—NOS3—glaucoma	2.75e-06	1.32e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—NOS3—glaucoma	2.71e-06	1.3e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—CDKN1B—glaucoma	2.7e-06	1.29e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—MTHFR—glaucoma	2.69e-06	1.29e-05	CbGpPWpGaD
Dasatinib—SRC—Immune System—CDKN1B—glaucoma	2.68e-06	1.28e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—APOE—glaucoma	2.67e-06	1.28e-05	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—VEGFA—glaucoma	2.66e-06	1.27e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—MMP9—glaucoma	2.64e-06	1.27e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—CAV1—glaucoma	2.64e-06	1.26e-05	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—PTGS2—glaucoma	2.63e-06	1.26e-05	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—NOS3—glaucoma	2.61e-06	1.25e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—NOS3—glaucoma	2.61e-06	1.25e-05	CbGpPWpGaD
Dasatinib—SRC—Disease—PTGS2—glaucoma	2.61e-06	1.25e-05	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—TP53—glaucoma	2.6e-06	1.24e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—NOS3—glaucoma	2.58e-06	1.23e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—MTHFR—glaucoma	2.54e-06	1.21e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—FN1—glaucoma	2.51e-06	1.2e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—MMP9—glaucoma	2.5e-06	1.2e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—APOE—glaucoma	2.5e-06	1.2e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—BAD—glaucoma	2.48e-06	1.19e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—CAV1—glaucoma	2.48e-06	1.19e-05	CbGpPWpGaD
Dasatinib—SRC—Disease—CDKN1B—glaucoma	2.47e-06	1.18e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—CDKN1B—glaucoma	2.44e-06	1.17e-05	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—PTGS2—glaucoma	2.39e-06	1.14e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—CDKN1B—glaucoma	2.38e-06	1.14e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—VEGFA—glaucoma	2.38e-06	1.14e-05	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—TP53—glaucoma	2.37e-06	1.14e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—APOE—glaucoma	2.36e-06	1.13e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—CDKN1B—glaucoma	2.35e-06	1.12e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—CAV1—glaucoma	2.34e-06	1.12e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	2.32e-06	1.11e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—GSTM1—glaucoma	2.29e-06	1.1e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—CYP1B1—glaucoma	2.29e-06	1.1e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—ABCA1—glaucoma	2.29e-06	1.1e-05	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—TP53—glaucoma	2.29e-06	1.1e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—CDKN1B—glaucoma	2.26e-06	1.08e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—NOS3—glaucoma	2.26e-06	1.08e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—MMP9—glaucoma	2.26e-06	1.08e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—VEGFA—glaucoma	2.25e-06	1.08e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—CDKN1B—glaucoma	2.23e-06	1.07e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—GSTT1—glaucoma	2.22e-06	1.06e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—MMP9—glaucoma	2.21e-06	1.06e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—MMP9—glaucoma	2.17e-06	1.04e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—MMP9—glaucoma	2.09e-06	1e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—MMP9—glaucoma	2.07e-06	9.89e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—MTHFR—glaucoma	2.03e-06	9.7e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—VEGFA—glaucoma	2.03e-06	9.69e-06	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—TP53—glaucoma	2.01e-06	9.62e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—NOS3—glaucoma	2e-06	9.56e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—VEGFA—glaucoma	1.98e-06	9.49e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—CDKN1B—glaucoma	1.95e-06	9.35e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—VEGFA—glaucoma	1.95e-06	9.34e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—APOE—glaucoma	1.89e-06	9.03e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—VEGFA—glaucoma	1.88e-06	9e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—NOS3—glaucoma	1.87e-06	8.96e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—CAV1—glaucoma	1.87e-06	8.95e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—VEGFA—glaucoma	1.86e-06	8.88e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—GSTM1—glaucoma	1.83e-06	8.76e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—MMP9—glaucoma	1.81e-06	8.66e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—TP53—glaucoma	1.79e-06	8.59e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—NOS3—glaucoma	1.77e-06	8.47e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—CYP1B1—glaucoma	1.77e-06	8.46e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—ABCA1—glaucoma	1.77e-06	8.46e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—CDKN1B—glaucoma	1.73e-06	8.28e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—PTGS2—glaucoma	1.71e-06	8.2e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—TP53—glaucoma	1.7e-06	8.13e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—VEGFA—glaucoma	1.63e-06	7.78e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—PTGS2—glaucoma	1.62e-06	7.75e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—MTHFR—glaucoma	1.62e-06	7.74e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—MMP9—glaucoma	1.6e-06	7.67e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—TP53—glaucoma	1.53e-06	7.33e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—APOE—glaucoma	1.51e-06	7.21e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—TP53—glaucoma	1.5e-06	7.17e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—CAV1—glaucoma	1.49e-06	7.14e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—TP53—glaucoma	1.48e-06	7.06e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—VEGFA—glaucoma	1.44e-06	6.89e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—TP53—glaucoma	1.42e-06	6.8e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—NOS3—glaucoma	1.41e-06	6.76e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—GSTM1—glaucoma	1.41e-06	6.76e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—TP53—glaucoma	1.4e-06	6.71e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—PTGS2—glaucoma	1.29e-06	6.19e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—MTHFR—glaucoma	1.25e-06	5.98e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—TP53—glaucoma	1.23e-06	5.88e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—APOE—glaucoma	1.16e-06	5.56e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—CAV1—glaucoma	1.15e-06	5.51e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—NOS3—glaucoma	1.13e-06	5.4e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—TP53—glaucoma	1.09e-06	5.2e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—PTGS2—glaucoma	1.03e-06	4.94e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—NOS3—glaucoma	8.71e-07	4.17e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—PTGS2—glaucoma	7.96e-07	3.81e-06	CbGpPWpGaD
